Full-Time

Lead Cyber Threat Intelligence Data Architect

Deadline 9/17/26
Humana

Humana

10,001+ employees

Medicare Advantage health insurer for seniors

Compensation Overview

$129.3k - $177.8k/yr

+ Bonus incentive

Boston, MA, USA + 9 more

More locations: Louisville, KY, USA | Nashville, TN, USA | Washington, DC, USA | Tampa, FL, USA | Miami, FL, USA | Dallas, TX, USA | Chicago, IL, USA | Charlotte, NC, USA | New York, NY, USA

Remote

Remote position; occasional travel to Humana offices for training or meetings may be required.

Bachelor's

Category
Cybersecurity (1)
Required Skills
Vulnerability Analysis

Get referred to Humana

See people who can refer or advise you

Requirements
  • The role requires 7+ years of related experience across cyber threat intelligence, security data platforms, or intelligence infrastructure, including experience leading projects or functional initiatives.
  • The candidate must understand how artificial intelligence and automated systems consume structured data and be able to organize threat intelligence for analysts and AI-driven tools.
  • A Bachelor's degree or equivalent experience is required.
  • The candidate must understand cyber threat intelligence workflows, collection management, and intelligence requirements.
  • The candidate must demonstrate intellectual curiosity and adaptability.
  • The candidate must have a firm understanding of the cyber threat landscape.
  • The candidate must have experience administering a threat intelligence platform, ideally Anomali ThreatStream.
  • The candidate must have experience structuring threat intelligence data, designing schemas, and building application programming interface integrations.
  • The candidate must be able to independently own a technical function and drive standards across stakeholders.
  • Home employees must have internet service with at least 25 Mbps download and 10 Mbps upload speeds and a dedicated workspace without ongoing interruptions to protect member protected health information and HIPAA information.
Responsibilities
  • Own Anomali ThreatStream administration, configuration, and platform strategy.
  • Manage threat intelligence feeds, integrations, data quality, and platform governance.
  • Serve as the subject matter expert to cyber threat intelligence analysts and stakeholder teams on threat intelligence data structure, integration, and delivery.
  • Set and evolve standards, methods, and best practices for structuring, maintaining, and delivering cyber threat intelligence for analysts and artificial intelligence systems.
  • Design and maintain cyber threat intelligence organization so it is consistent, searchable, reusable, and reliably consumable by artificial intelligence agents and automated systems.
  • Build workflows and pipelines that turn analytical work into structured intelligence records optimized for human use and artificial intelligence consumption.
  • Own the technical relationship with stakeholders that consume cyber threat intelligence through artificial intelligence agents, automated systems, and other tools.
  • Manage application programming interface access, data versioning, and analytics on downstream use of cyber threat intelligence data.
  • Work with consuming teams to understand the threat intelligence required by their artificial intelligence and automation workflows and ensure it is available in a usable form.
  • Identify opportunities to improve tools, workflows, and processes affecting cyber threat intelligence support for security operations, detection engineering, and vulnerability management.
  • Own the collection plan and ensure sources align with intelligence requirements and stakeholder information needs.
  • Evaluate source quality, timeliness, and value to ensure intelligence meets stakeholder needs.
Desired Qualifications
  • Familiarity with MITRE ATT&CK, STIX/TAXII, and other structured intelligence frameworks.
  • Experience integrating threat intelligence with detection engineering, security operations centers, or vulnerability management workflows.

Humana focuses on health and well-being by offering Medicare Advantage plans (HMO, PPO, and PFFS) mainly for seniors, military personnel, and communities. Its products are health insurance plans funded through a mix of government contracts and member premiums, enrolling members to provide comprehensive coverage with flexible benefits and a broad provider network. Members receive care through a network of providers, with additional services such as free language interpretation to improve accessibility. Humana differentiates itself through its emphasis on inclusivity, accessibility, and tailored benefits, aiming to deliver reliable service and high renewal rates. The goal is to improve health outcomes and overall well-being for members by delivering coverage that meets diverse needs and making care accessible to all.

Company Size

10,001+

Company Stage

IPO

Headquarters

Louisville, Kentucky

Founded

1961

Get referred to Humana

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Second-quarter 2026 revenue reached $40.87 billion, up 26.2%, beating estimates.
  • Illinois awarded Humana a statewide Medicaid contract starting January 2027, broadening state footing.
  • Humana expects 2027 MA membership growth of roughly 25%, despite plan exits.

What critics are saying

  • CMS star-rating losses cut 2026 GAAP EPS guidance to at least $6.52.
  • 2027 plan exits hit 600,000 members, risking churn and weaker brand trust.
  • Texas appeal loss or further CMS downgrades can erase billions in MA bonuses.

What makes Humana unique

  • Humana leads Medicare Advantage with 6.45 million individual MA members in 2026.
  • CenterWell and Medicaid expansion add care delivery and government-contract diversification beyond insurance.
  • August 2026 board adds Anthropic's Paul Smith, signaling faster AI-enabled care operations.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Unlimited Paid Time Off

Paid Vacation

Paid Parental Leave

Short-term Disability

Long-term Disability

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

6%

2 year growth

6%
PR Newswire
Sep 2nd, 2026
Thyme Care raises $125M at $2B+ valuation to expand oncology care model

Thyme Care, a Nashville-based oncology company, has closed a Series E funding round of more than $125 million at a valuation exceeding $2 billion. Morgan Health led the round, with participation from CVS Health Ventures, Humana, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health. The company now serves over 10.5 million people across all 50 US states and manages more than $7 billion in oncology spend. Thyme Care reports it is profitable with positive free cash flow whilst delivering validated reductions of 5 to 10 per cent in total cost of care. Alongside the funding, Thyme Care is establishing Thyme Companies, a parent entity that will build a portfolio of independent oncology businesses addressing care barriers. Co-founder Robin Shah will serve as executive chairman of the new entity.

Associated Press
Aug 20th, 2026
Humana appoints Dr. Shantanu Nundy as chief medical officer to lead AI and digital care strategy

Humana has appointed Dr Shantanu Nundy as Chief Medical Officer, effective 31 August. Dr Nundy, a practicing physician and healthcare executive, will help shape the company's products, platforms, and use of AI whilst bringing clinical expertise to the enterprise. He most recently served as Executive Vice President of Care Delivery and Chief Health Officer at Accolade, a healthcare navigation company. Previously, he was Managing Director for Clinical Innovation at Evolent Health, driving value-based and digital care transformation across health systems. Dr Nundy will report to Jim Rechtin, Humana's President and CEO, and join the company's Enterprise Leadership Team. He continues to practice primary care and hospital medicine.

Yahoo Finance
Aug 19th, 2026
Humana beats Q2 revenue estimates with $40.87B as health insurers face regulatory scrutiny

Humana reported Q2 revenues of $40.87 billion, up 26.2% year on year, exceeding analysts' expectations by 0.6%. The health insurance provider also beat earnings per share estimates. Despite the relatively strong results, Humana's stock has fallen 2.7% since the earnings announcement and currently trades at $378.11. The health insurance sector as a whole showed resilience in Q2, with the 12 tracked providers beating revenue consensus estimates by 2.8% on average. However, share prices across the sector have declined an average of 5.8% since reporting. Humana derives over 80% of its revenue from federal government contracts and serves approximately 17 million members, with a strong focus on Medicare Advantage plans for seniors.

Yahoo Finance
Aug 17th, 2026
Health insurers drop Medicare Advantage plans affecting nearly 3M older Americans

Nearly 3 million older Americans will lose their Medicare Advantage plans this year, according to Johns Hopkins Bloomberg School of Public Health research. One in 10 Medicare Advantage policyholders face forced disenrollment, with Vermont hit hardest at 92% of policyholders affected. Humana announced its exit from multiple markets for the second consecutive year, impacting 600,000 members. The company reported $1.9 billion profit in the first half of 2026. Insurers cite financial pressures from federal policy changes aimed at reducing overpayments, resulting in lower government reimbursement rates. Combined with rising medical costs, these factors are squeezing profit margins. Shannon Benton of Senior Citizens League said Humana's decision shows Medicare Advantage insurers are "prioritising profit growth over enrollment growth.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.